NIH-funded research R01 grant

How gut bacteria metabolites affect your immune system and allergies

Official title: Microbiota-derived metabolites and the regulation of host immunity and inflammation

Funded at Weill Medical Coll of Cornell Univ · NIH-11520822 · Data updated 2026-11-12

This project looks at how substances made by the gut microbiome influence the body’s immune responses to allergic diseases and intestinal infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startJune 14, 2022
Project endMay 31, 2027
Funding year2026
Award (this year)$141,266
NIH project number3R01AI172027-05S1
Project IDNIH-11520822 on NIH RePORTER

Who could benefit from this research

Could help

Patients with allergic diseases or intestinal infections who are able to provide samples or participate in related studies may be eligible.

Less likely to help

Individuals without allergic disease or gut-related conditions may not directly benefit from this study.

What this research studies

If you have allergic disease or are affected by intestinal parasites, this research explores the tiny molecules produced by gut microbes and how they shape immune cells. The study uses laboratory analyses and animal or human samples to uncover the mechanisms by which diet, microbiota, and these metabolites modulate type 2 immunity and inflammation. The findings could point to new ways to prevent or treat allergies and infections by targeting microbiome signals. The work is led by Weill Cornell Medicine researchers and aims to translate basic knowledge into strategies for better allergy and infection control.

Why it matters

Potential benefit: Understanding these mechanisms could lead to new dietary or microbiome-based approaches to reduce allergy symptoms and improve resistance to intestinal infections.

How similar studies have gone: Previous studies indicate microbiome-derived metabolites can influence immune responses, supporting the potential relevance of this approach.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Artis, David — Weill Medical Coll of Cornell Univ
  • Study coordinator: Artis, David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.